Evidence map›Paper›PMID 39697403›Full record

ReviewSeminars in plastic surgery2024

Mohs Micrographic Surgery: A Brief Overview.

A Caresse Gamret, Jared E Roberts, Divya Srivastava, Rajiv I Nijhawan

Registry-linked trialAbstract readReview
In one paragraph

Review in Seminars in plastic surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06919809 (Efficacy and Safety of X A-DERM™ Microsurfaced Acellular Dermal Matrix), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06919809 nacompletednot on this mapstarted 2025, after this paper: background citation

Efficacy and Safety of X A-DERM™ Microsurfaced Acellular Dermal Matrix (mADM) for Enhancing Wound Healing Following Mohs Micrographic Surgery (MMS)

TypeinterventionalSponsorMcGuire InstituteRan2025 to 2026Enrolled16ConditionsWound Healing After MMS Surgery, BCC - Basal Cell Carcinoma, SCC - Squamous Cell Carcinoma, Melanoma In SituArmsA microsurfaced ADM (acellular dermal matrix)
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

A Caresse GamretDepartment of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas.
Jared E RobertsDepartment of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas.
Divya SrivastavaDepartment of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas.
Rajiv I NijhawanDepartment of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mohs micrographic surgery (MMS) is a tissue-sparing skin cancer resection technique that involves 100% margin analysis. This procedure is performed in the outpatient setting under local anesthesia by dermatologic surgeons who act as both the surgeon and the pathologist. The technique allows for prompt reconstruction immediately after cancer clearance and offers the highest cure rate for many skin malignancies, including basal and squamous cell carcinoma, as well as more rare tumors. Mohs surgery effectively ensures cancer clearance while minimizing defect size and optimizing cosmetic and functional outcomes for patients. Herein we will discuss the evolution, procedure, and indications of MMS.

Indexed as

cutaneous malignancyMohs micrographic surgeryMohs surgeryskin cancer

Identifiers

PMID39697403
PMCPMC11651823

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.